Herpes Simplex Virus Treatment Market Report by Type (Herpes Simples Virus-1 Infection, Herpes Simplex Virus-2 Infection, and Others), Drug Type (Acyclovir, Valacyclovir, Famciclovir, and Others), Route of Administration (Oral, Injectable, Topical), Distribution Channel (Hospital Pharmacy, Drug Stores, Retail Stores, Online Pharmacy), and Region 2024-2032
The global herpes simplex virus treatment market size reached US$ 2.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.0 Billion by 2032, exhibiting a growth rate (CAGR) of 4.7% during 2024-2032. The growing awareness among individuals about various medications of HSV, increasing healthcare expenditure, and wide availability of HSV medications through online and offline pharmacy stores represent some of the key factors driving the market.
Herpes simplex virus (HSV) refers to a contagious viral infection that is spread through saliva, semen, and vaginal secretion and causes blisters and ulcers. It produces herpes simplex virus-1 (HSV-1) infection and herpes simplex virus-2 (HSV-2) infection among individuals. It also causes fever, body aches, swollen lymph nodes, headache, tingling, itching, or burning sensation around the mouth of an individual before the appearance of sores. It usually occurs among people having a sexual partner with HSV or who are immunocompromised. HSV can be cured by consuming some antiviral medications, such as acyclovir, famciclovir, and valacyclovir. It can also be treated through some home remedies, such as a warm or cold compress, aloe vera, a paste of baking soda or cornstarch and water, and a mixture of crushed garlic. HSV treatment can aid in lowering the chance of transmitting the virus and reducing the frequency or severity of outbreaks.
Herpes Simplex Virus Treatment Market Trends:
At present, the rising prevalence of sexually transmitted infections (STIs) among the masses around the world represents one of the key factors supporting the growth of the market. In addition, the increasing demand for HSV treatments due to concerns about sexual health among individuals worldwide is bolstering the growth of the market. Besides this, the growing demand for HSV treatments due to the increasing awareness among individuals about the risks and complications of HSV infection across the globe is positively influencing the market. Moreover, the rising demand for new HSV treatment options with reduced side effects and enhanced effectiveness is propelling the growth of the market. Apart from this, the increasing healthcare expenditure, along with the inflating income level of individuals, is offering lucrative growth opportunities to industry investors. Additionally, the wide availability of HSV medications through online and offline pharmacy stores across the globe is impelling the growth of the market. Besides this, the increasing demand for HSV treatment options to prevent severe complications, such as encephalitis (brain infection) or keratitis (eye infection) among individuals, is contributing to the growth of the market. Furthermore, the rising innovations in HSV treatment options and various drug approvals are strengthening the growth of the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global herpes simplex virus treatment market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, drug type, route of administration and distribution channel.
Type Insights:
Herpes Simples Virus-1 Infection
Herpes Simplex Virus-2 Infection
Others
The report has provided a detailed breakup and analysis of the herpes simplex virus treatment market based on the type. This includes herpes simples virus-1 infection, herpes simplex virus-2 infection, and others.
Drug Type Insights:
Acyclovir
Valacyclovir
Famciclovir
Others
A detailed breakup and analysis of the herpes simplex virus treatment market based on the drug type has also been provided in the report. This includes acyclovir, valacyclovir, famciclovir, and others. According to the report, acyclovir accounted for the largest market share.
Route of Administration Insights:
Oral
Injectable
Topical
A detailed breakup and analysis of the herpes simplex virus treatment market based on the route of administration has also been provided in the report. This includes oral, injectable, and topical. According to the report, oral accounted for the largest market share.
Distribution Channel Insights:
Hospital Pharmacy
Drug Stores
Retail Stores
Online Pharmacy
A detailed breakup and analysis of the herpes simplex virus treatment market based on the distribution channel has also been provided in the report. This includes hospital pharmacy, drug stores, retail stores, and online pharmacy. According to the report, hospital pharmacy accounted for the largest market share.
Regional Insights:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America (the United States and Canada) was the largest market for herpes simplex virus treatment. Some of the factors driving the North America herpes simplex virus treatment market included the growing prevalence of HSV infection among individuals, increasing number of clinical trials for its treatment, rising awareness about various medications of HSV, etc.
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global herpes simplex virus treatment market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Agenus Inc., Apotex Inc., Avet Pharmaceuticals Inc., Carlsbad Tech, EPI Health LLC, F. Hoffmann-La Roche Ltd, Fresenius SE & Co. KGaA, GlaxoSmithKline plc, Glenmark Pharmaceuticals Limited, Merck & Co. Inc., Novartis AG, Sanofi S.A., Teva Pharmaceutical Industries Ltd., Viatris Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report
1. How big is the global herpes simplex virus treatment market?
2. What is the expected growth rate of the global herpes simplex virus treatment market during 2024-2032?
3. What are the key factors driving the global herpes simplex virus treatment market?
4. What has been the impact of COVID-19 on the global herpes simplex virus treatment market?
5. What is the breakup of the global herpes simplex virus treatment market based on the drug type?
6. What is the breakup of the global herpes simplex virus treatment market based on the route of administration?
7. What is the breakup of the global herpes simplex virus treatment market based on the distribution channel?
8. What are the key regions in the global herpes simplex virus treatment market?
9. Who are the key players/companies in the global herpes simplex virus treatment market?
Herpes simplex virus (HSV) refers to a contagious viral infection that is spread through saliva, semen, and vaginal secretion and causes blisters and ulcers. It produces herpes simplex virus-1 (HSV-1) infection and herpes simplex virus-2 (HSV-2) infection among individuals. It also causes fever, body aches, swollen lymph nodes, headache, tingling, itching, or burning sensation around the mouth of an individual before the appearance of sores. It usually occurs among people having a sexual partner with HSV or who are immunocompromised. HSV can be cured by consuming some antiviral medications, such as acyclovir, famciclovir, and valacyclovir. It can also be treated through some home remedies, such as a warm or cold compress, aloe vera, a paste of baking soda or cornstarch and water, and a mixture of crushed garlic. HSV treatment can aid in lowering the chance of transmitting the virus and reducing the frequency or severity of outbreaks.
Herpes Simplex Virus Treatment Market Trends:
At present, the rising prevalence of sexually transmitted infections (STIs) among the masses around the world represents one of the key factors supporting the growth of the market. In addition, the increasing demand for HSV treatments due to concerns about sexual health among individuals worldwide is bolstering the growth of the market. Besides this, the growing demand for HSV treatments due to the increasing awareness among individuals about the risks and complications of HSV infection across the globe is positively influencing the market. Moreover, the rising demand for new HSV treatment options with reduced side effects and enhanced effectiveness is propelling the growth of the market. Apart from this, the increasing healthcare expenditure, along with the inflating income level of individuals, is offering lucrative growth opportunities to industry investors. Additionally, the wide availability of HSV medications through online and offline pharmacy stores across the globe is impelling the growth of the market. Besides this, the increasing demand for HSV treatment options to prevent severe complications, such as encephalitis (brain infection) or keratitis (eye infection) among individuals, is contributing to the growth of the market. Furthermore, the rising innovations in HSV treatment options and various drug approvals are strengthening the growth of the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global herpes simplex virus treatment market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, drug type, route of administration and distribution channel.
Type Insights:
Herpes Simples Virus-1 Infection
Herpes Simplex Virus-2 Infection
Others
The report has provided a detailed breakup and analysis of the herpes simplex virus treatment market based on the type. This includes herpes simples virus-1 infection, herpes simplex virus-2 infection, and others.
Drug Type Insights:
Acyclovir
Valacyclovir
Famciclovir
Others
A detailed breakup and analysis of the herpes simplex virus treatment market based on the drug type has also been provided in the report. This includes acyclovir, valacyclovir, famciclovir, and others. According to the report, acyclovir accounted for the largest market share.
Route of Administration Insights:
Oral
Injectable
Topical
A detailed breakup and analysis of the herpes simplex virus treatment market based on the route of administration has also been provided in the report. This includes oral, injectable, and topical. According to the report, oral accounted for the largest market share.
Distribution Channel Insights:
Hospital Pharmacy
Drug Stores
Retail Stores
Online Pharmacy
A detailed breakup and analysis of the herpes simplex virus treatment market based on the distribution channel has also been provided in the report. This includes hospital pharmacy, drug stores, retail stores, and online pharmacy. According to the report, hospital pharmacy accounted for the largest market share.
Regional Insights:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America (the United States and Canada) was the largest market for herpes simplex virus treatment. Some of the factors driving the North America herpes simplex virus treatment market included the growing prevalence of HSV infection among individuals, increasing number of clinical trials for its treatment, rising awareness about various medications of HSV, etc.
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global herpes simplex virus treatment market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Agenus Inc., Apotex Inc., Avet Pharmaceuticals Inc., Carlsbad Tech, EPI Health LLC, F. Hoffmann-La Roche Ltd, Fresenius SE & Co. KGaA, GlaxoSmithKline plc, Glenmark Pharmaceuticals Limited, Merck & Co. Inc., Novartis AG, Sanofi S.A., Teva Pharmaceutical Industries Ltd., Viatris Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report
1. How big is the global herpes simplex virus treatment market?
2. What is the expected growth rate of the global herpes simplex virus treatment market during 2024-2032?
3. What are the key factors driving the global herpes simplex virus treatment market?
4. What has been the impact of COVID-19 on the global herpes simplex virus treatment market?
5. What is the breakup of the global herpes simplex virus treatment market based on the drug type?
6. What is the breakup of the global herpes simplex virus treatment market based on the route of administration?
7. What is the breakup of the global herpes simplex virus treatment market based on the distribution channel?
8. What are the key regions in the global herpes simplex virus treatment market?
9. Who are the key players/companies in the global herpes simplex virus treatment market?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL HERPES SIMPLEX VIRUS TREATMENT MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY TYPE
6.1 Herpes Simples Virus-1 Infection
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Herpes Simplex Virus-2 Infection
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Others
6.3.1 Market Trends
6.3.2 Market Forecast
7 MARKET BREAKUP BY DRUG TYPE
7.1 Acyclovir
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Valacyclovir
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Famciclovir
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 MARKET BREAKUP BY ROUTE OF ADMINISTRATION
8.1 Oral
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Injectable
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Topical
8.3.1 Market Trends
8.3.2 Market Forecast
9 MARKET BREAKUP BY DISTRIBUTION CHANNEL
9.1 Hospital Pharmacy
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Drug Stores
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Retail Stores
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Online Pharmacy
9.4.1 Market Trends
9.4.2 Market Forecast
10 MARKET BREAKUP BY REGION
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT ANALYSIS
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 VALUE CHAIN ANALYSIS
13 PORTERS FIVE FORCES ANALYSIS
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 PRICE ANALYSIS
15 COMPETITIVE LANDSCAPE
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Agenus Inc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Apotex Inc.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 SWOT Analysis
15.3.3 Avet Pharmaceuticals Inc.
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.4 Carlsbad Tech
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.5 EPI Health LLC
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.6 F. Hoffmann-La Roche Ltd
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.7 Fresenius SE & Co. KGaA
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 GlaxoSmithKline plc
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Glenmark Pharmaceuticals Limited
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Merck & Co. Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 Novartis AG
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
15.3.12 Sanofi S.A.
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
15.3.12.4 SWOT Analysis
15.3.13 Teva Pharmaceutical Industries Ltd.
15.3.13.1 Company Overview
15.3.13.2 Product Portfolio
15.3.13.3 Financials
15.3.13.4 SWOT Analysis
15.3.14 Viatris Inc.
15.3.14.1 Company Overview
15.3.14.2 Product Portfolio
15.3.14.3 Financials
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL HERPES SIMPLEX VIRUS TREATMENT MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY TYPE
6.1 Herpes Simples Virus-1 Infection
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Herpes Simplex Virus-2 Infection
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Others
6.3.1 Market Trends
6.3.2 Market Forecast
7 MARKET BREAKUP BY DRUG TYPE
7.1 Acyclovir
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Valacyclovir
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Famciclovir
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 MARKET BREAKUP BY ROUTE OF ADMINISTRATION
8.1 Oral
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Injectable
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Topical
8.3.1 Market Trends
8.3.2 Market Forecast
9 MARKET BREAKUP BY DISTRIBUTION CHANNEL
9.1 Hospital Pharmacy
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Drug Stores
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Retail Stores
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Online Pharmacy
9.4.1 Market Trends
9.4.2 Market Forecast
10 MARKET BREAKUP BY REGION
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT ANALYSIS
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 VALUE CHAIN ANALYSIS
13 PORTERS FIVE FORCES ANALYSIS
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 PRICE ANALYSIS
15 COMPETITIVE LANDSCAPE
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Agenus Inc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Apotex Inc.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 SWOT Analysis
15.3.3 Avet Pharmaceuticals Inc.
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.4 Carlsbad Tech
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.5 EPI Health LLC
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.6 F. Hoffmann-La Roche Ltd
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.7 Fresenius SE & Co. KGaA
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 GlaxoSmithKline plc
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Glenmark Pharmaceuticals Limited
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Merck & Co. Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 Novartis AG
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
15.3.12 Sanofi S.A.
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
15.3.12.4 SWOT Analysis
15.3.13 Teva Pharmaceutical Industries Ltd.
15.3.13.1 Company Overview
15.3.13.2 Product Portfolio
15.3.13.3 Financials
15.3.13.4 SWOT Analysis
15.3.14 Viatris Inc.
15.3.14.1 Company Overview
15.3.14.2 Product Portfolio
15.3.14.3 Financials
LIST OF TABLES
Table 1: Global: Herpes Simplex Virus Treatment Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Herpes Simplex Virus Treatment Market Forecast: Breakup by Type (in Million US$), 2024-2032
Table 3: Global: Herpes Simplex Virus Treatment Market Forecast: Breakup by Drug Type (in Million US$), 2024-2032
Table 4: Global: Herpes Simplex Virus Treatment Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
Table 5: Global: Herpes Simplex Virus Treatment Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
Table 6: Global: Herpes Simplex Virus Treatment Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 7: Global: Herpes Simplex Virus Treatment Market: Competitive Structure
Table 8: Global: Herpes Simplex Virus Treatment Market: Key Players
Table 1: Global: Herpes Simplex Virus Treatment Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Herpes Simplex Virus Treatment Market Forecast: Breakup by Type (in Million US$), 2024-2032
Table 3: Global: Herpes Simplex Virus Treatment Market Forecast: Breakup by Drug Type (in Million US$), 2024-2032
Table 4: Global: Herpes Simplex Virus Treatment Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
Table 5: Global: Herpes Simplex Virus Treatment Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
Table 6: Global: Herpes Simplex Virus Treatment Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 7: Global: Herpes Simplex Virus Treatment Market: Competitive Structure
Table 8: Global: Herpes Simplex Virus Treatment Market: Key Players
LIST OF FIGURES
Figure 1: Global: Herpes Simplex Virus Treatment Market: Major Drivers and Challenges
Figure 2: Global: Herpes Simplex Virus Treatment Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Herpes Simplex Virus Treatment Market: Breakup by Type (in %), 2023
Figure 5: Global: Herpes Simplex Virus Treatment Market: Breakup by Drug Type (in %), 2023
Figure 6: Global: Herpes Simplex Virus Treatment Market: Breakup by Route of Administration (in %), 2023
Figure 7: Global: Herpes Simplex Virus Treatment Market: Breakup by Distribution Channel (in %), 2023
Figure 8: Global: Herpes Simplex Virus Treatment Market: Breakup by Region (in %), 2023
Figure 9: Global: Herpes Simplex Virus Treatment (Herpes Simples Virus-1 Infection) Market: Sales Value (in Million US$), 2018 & 2023
Figure 10: Global: Herpes Simplex Virus Treatment (Herpes Simples Virus-1 Infection) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 11: Global: Herpes Simplex Virus Treatment (Herpes Simplex Virus-2 Infection) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: Herpes Simplex Virus Treatment (Herpes Simplex Virus-2 Infection) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: Herpes Simplex Virus Treatment (Other Types) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Herpes Simplex Virus Treatment (Other Types) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Herpes Simplex Virus Treatment (Acyclovir) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Herpes Simplex Virus Treatment (Acyclovir) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Herpes Simplex Virus Treatment (Valacyclovir) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Herpes Simplex Virus Treatment (Valacyclovir) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: Herpes Simplex Virus Treatment (Famciclovir) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: Herpes Simplex Virus Treatment (Famciclovir) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: Herpes Simplex Virus Treatment (Other Drug Types) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: Herpes Simplex Virus Treatment (Other Drug Types) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: Herpes Simplex Virus Treatment (Oral) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: Herpes Simplex Virus Treatment (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Global: Herpes Simplex Virus Treatment (Injectable) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Global: Herpes Simplex Virus Treatment (Injectable) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Global: Herpes Simplex Virus Treatment (Topical) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Global: Herpes Simplex Virus Treatment (Topical) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Global: Herpes Simplex Virus Treatment (Hospital Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Global: Herpes Simplex Virus Treatment (Hospital Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: Global: Herpes Simplex Virus Treatment (Drug Stores) Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: Global: Herpes Simplex Virus Treatment (Drug Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: Global: Herpes Simplex Virus Treatment (Retail Stores) Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: Global: Herpes Simplex Virus Treatment (Retail Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: Global: Herpes Simplex Virus Treatment (Online Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: Global: Herpes Simplex Virus Treatment (Online Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: North America: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: North America: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: United States: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: United States: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: Canada: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: Canada: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: Asia-Pacific: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: Asia-Pacific: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: China: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: China: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: Japan: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: Japan: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: India: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: India: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: South Korea: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: South Korea: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: Australia: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: Australia: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: Indonesia: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: Indonesia: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: Others: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: Others: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: Europe: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: Europe: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: Germany: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: Germany: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: France: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: France: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: United Kingdom: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: United Kingdom: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 67: Italy: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 68: Italy: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 69: Spain: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 70: Spain: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: Russia: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 72: Russia: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: Others: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 74: Others: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: Latin America: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 76: Latin America: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 77: Brazil: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 78: Brazil: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 79: Mexico: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 80: Mexico: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 81: Others: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 82: Others: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 83: Middle East and Africa: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 84: Middle East and Africa: Herpes Simplex Virus Treatment Market: Breakup by Country (in %), 2023
Figure 85: Middle East and Africa: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 86: Global: Herpes Simplex Virus Treatment Industry: SWOT Analysis
Figure 87: Global: Herpes Simplex Virus Treatment Industry: Value Chain Analysis
Figure 88: Global: Herpes Simplex Virus Treatment Industry: Porter's Five Forces Analysis
Figure 1: Global: Herpes Simplex Virus Treatment Market: Major Drivers and Challenges
Figure 2: Global: Herpes Simplex Virus Treatment Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Herpes Simplex Virus Treatment Market: Breakup by Type (in %), 2023
Figure 5: Global: Herpes Simplex Virus Treatment Market: Breakup by Drug Type (in %), 2023
Figure 6: Global: Herpes Simplex Virus Treatment Market: Breakup by Route of Administration (in %), 2023
Figure 7: Global: Herpes Simplex Virus Treatment Market: Breakup by Distribution Channel (in %), 2023
Figure 8: Global: Herpes Simplex Virus Treatment Market: Breakup by Region (in %), 2023
Figure 9: Global: Herpes Simplex Virus Treatment (Herpes Simples Virus-1 Infection) Market: Sales Value (in Million US$), 2018 & 2023
Figure 10: Global: Herpes Simplex Virus Treatment (Herpes Simples Virus-1 Infection) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 11: Global: Herpes Simplex Virus Treatment (Herpes Simplex Virus-2 Infection) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: Herpes Simplex Virus Treatment (Herpes Simplex Virus-2 Infection) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: Herpes Simplex Virus Treatment (Other Types) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Herpes Simplex Virus Treatment (Other Types) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Herpes Simplex Virus Treatment (Acyclovir) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Herpes Simplex Virus Treatment (Acyclovir) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Herpes Simplex Virus Treatment (Valacyclovir) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Herpes Simplex Virus Treatment (Valacyclovir) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: Herpes Simplex Virus Treatment (Famciclovir) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: Herpes Simplex Virus Treatment (Famciclovir) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: Herpes Simplex Virus Treatment (Other Drug Types) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: Herpes Simplex Virus Treatment (Other Drug Types) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: Herpes Simplex Virus Treatment (Oral) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: Herpes Simplex Virus Treatment (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Global: Herpes Simplex Virus Treatment (Injectable) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Global: Herpes Simplex Virus Treatment (Injectable) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Global: Herpes Simplex Virus Treatment (Topical) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Global: Herpes Simplex Virus Treatment (Topical) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Global: Herpes Simplex Virus Treatment (Hospital Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Global: Herpes Simplex Virus Treatment (Hospital Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: Global: Herpes Simplex Virus Treatment (Drug Stores) Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: Global: Herpes Simplex Virus Treatment (Drug Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: Global: Herpes Simplex Virus Treatment (Retail Stores) Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: Global: Herpes Simplex Virus Treatment (Retail Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: Global: Herpes Simplex Virus Treatment (Online Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: Global: Herpes Simplex Virus Treatment (Online Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: North America: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: North America: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: United States: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: United States: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: Canada: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: Canada: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: Asia-Pacific: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: Asia-Pacific: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: China: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: China: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: Japan: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: Japan: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: India: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: India: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: South Korea: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: South Korea: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: Australia: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: Australia: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: Indonesia: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: Indonesia: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: Others: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: Others: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: Europe: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: Europe: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: Germany: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: Germany: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: France: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: France: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: United Kingdom: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: United Kingdom: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 67: Italy: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 68: Italy: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 69: Spain: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 70: Spain: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: Russia: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 72: Russia: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: Others: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 74: Others: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: Latin America: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 76: Latin America: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 77: Brazil: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 78: Brazil: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 79: Mexico: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 80: Mexico: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 81: Others: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 82: Others: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 83: Middle East and Africa: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 84: Middle East and Africa: Herpes Simplex Virus Treatment Market: Breakup by Country (in %), 2023
Figure 85: Middle East and Africa: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 86: Global: Herpes Simplex Virus Treatment Industry: SWOT Analysis
Figure 87: Global: Herpes Simplex Virus Treatment Industry: Value Chain Analysis
Figure 88: Global: Herpes Simplex Virus Treatment Industry: Porter's Five Forces Analysis
